2020-11-06

Camurus' Interim Report third quarter 2020

"Good performances were seen across markets and we are on track to deliver on our revenue guidance."

Read the full report on Camurus' website: https://www.camurus.com/

Latest news

2019-08-26

Camurus’ treatment Buvidal® subsidised in Australia

Australia has announced that Camurus’ treatment Buvidal® (buprenorphine) will be listed through the Pharmaceutical B…

Read more

2019-08-07

Three new products from ISEC

ISEC has launched three new products for better and safer surveillance of radioactive environments.

Read more

2019-07-23

Positive outcome for Camurus in court proceedings regarding final approval of Brixadi™ in the US

Camurus’ partner Braeburn have received a positive outcome in the US court proceedings which were initiated in April…

Read more

2019-06-20

FDA grants Camurus IND application to enter Phase 3 study with CAM2029 for treatment of acromegaly

The FDA has approved Camurus’ Investigational New Drug application to initiate a Phase 3 study with CAM2029 once-mon…

Read more

2019-06-17

Introducing the chemical-free office

Starting June 2019, all Sandberg Development's office and production facilities will be cleaned and washed with DIRO…

Read more